Andrew Oxtoby

Insider Reports History

Entity
Individual
Location
8000 Marina Boulevard, Suite 300, Brisbane, CA
Signature
/s/ Andrew Oxtoby
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Oxtoby:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CHINOOK THERAPEUTICS, INC. Chief Commercial Officer Restricted Stock (RSU)(Common Stock) 40K $932K $23.30 Feb 28, 2023 Direct
Kalaris Therapeutics, Inc. President and Chief Executive Officer, Director Stock Option (Right to Buy) 287K Apr 10, 2025 Direct
CHINOOK THERAPEUTICS, INC. Chief Commercial Officer Restricted Stock Units 0 Aug 11, 2023 Direct
CHINOOK THERAPEUTICS, INC. Chief Commercial Officer Stock Option (Right to Buy) 0 $26.12 Aug 11, 2023 Direct

Insider Reports Filed by Andrew Oxtoby

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KLRS Kalaris Therapeutics, Inc. Apr 10, 2025 1 $0 4 Apr 11, 2025 President and Chief Executive Officer, Director
KLRS Kalaris Therapeutics, Inc. Mar 18, 2025 1 $0 4 Mar 18, 2025 President and Chief Executive Officer, Director
KLRS Kalaris Therapeutics, Inc. Mar 18, 2025 0 $0 3 Mar 18, 2025 President and Chief Executive Officer Exhibit 24.1 - Power of Attorney, Director
KDNY CHINOOK THERAPEUTICS, INC. Aug 11, 2023 2 -$2.91M 4 Aug 11, 2023 Chief Commercial Officer
KDNY CHINOOK THERAPEUTICS, INC. Feb 28, 2023 2 $0 4 Mar 2, 2023 Chief Commercial Officer
KDNY CHINOOK THERAPEUTICS, INC. Feb 15, 2023 0 $0 3 Feb 16, 2023 Chief Commercial Officer